Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
Clinical trial NCT00730262 · TERMINATED
Trial details
- NCT number
- NCT00730262
- Sponsor
- Thallion Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.